nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—CYP3A4—bone cancer	0.404	1	CbGaD
Venlafaxine—ABCG2—Carboplatin—bone cancer	0.0708	0.187	CbGbCtD
Venlafaxine—ABCG2—Cisplatin—bone cancer	0.0605	0.16	CbGbCtD
Venlafaxine—CYP2B6—Cisplatin—bone cancer	0.0425	0.113	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—bone cancer	0.0405	0.107	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—bone cancer	0.0393	0.104	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—bone cancer	0.0285	0.0755	CbGbCtD
Venlafaxine—CYP2C9—Cisplatin—bone cancer	0.0225	0.0595	CbGbCtD
Venlafaxine—ABCB1—Cisplatin—bone cancer	0.0218	0.0577	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—bone cancer	0.0146	0.0387	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—bone cancer	0.0142	0.0375	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—bone cancer	0.0138	0.0365	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—bone cancer	0.00876	0.0232	CbGbCtD
Venlafaxine—Desvenlafaxine—CYP3A4—bone cancer	0.00251	0.627	CrCbGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.00192	0.0616	CbGpPWpGaD
Venlafaxine—Tramadol—CYP3A4—bone cancer	0.00149	0.373	CrCbGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00113	0.0362	CbGpPWpGaD
Venlafaxine—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00088	0.0283	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—FEV—bone cancer	0.000809	0.026	CbGpPWpGaD
Venlafaxine—ABCG2—Irinotecan Pathway—CYP3A4—bone cancer	0.000771	0.0248	CbGpPWpGaD
Venlafaxine—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00074	0.0238	CbGpPWpGaD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000665	0.0214	CbGpPWpGaD
Venlafaxine—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000652	0.021	CbGpPWpGaD
Venlafaxine—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000615	0.0197	CbGpPWpGaD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000612	0.0197	CbGpPWpGaD
Venlafaxine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000611	0.0196	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00061	0.0196	CbGpPWpGaD
Venlafaxine—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000607	0.0195	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—GRM4—bone cancer	0.000581	0.0187	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—RGS1—bone cancer	0.000581	0.0187	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00058	0.0186	CbGpPWpGaD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000476	0.0153	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.000458	0.0147	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000426	0.0137	CbGpPWpGaD
Venlafaxine—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000425	0.0136	CbGpPWpGaD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0004	0.0129	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000379	0.0122	CbGpPWpGaD
Venlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000376	0.0121	CbGpPWpGaD
Venlafaxine—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000357	0.0115	CbGpPWpGaD
Venlafaxine—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000353	0.0113	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—GRM4—bone cancer	0.000352	0.0113	CbGpPWpGaD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000351	0.0113	CbGpPWpGaD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000328	0.0105	CbGpPWpGaD
Venlafaxine—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000321	0.0103	CbGpPWpGaD
Venlafaxine—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000309	0.00992	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—GRM1—bone cancer	0.000305	0.00979	CbGpPWpGaD
Venlafaxine—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000295	0.00949	CbGpPWpGaD
Venlafaxine—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000293	0.0094	CbGpPWpGaD
Venlafaxine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000292	0.00937	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000286	0.0092	CbGpPWpGaD
Venlafaxine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000284	0.00912	CbGpPWpGaD
Venlafaxine—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000282	0.00904	CbGpPWpGaD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000278	0.00893	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000263	0.00846	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000261	0.00839	CbGpPWpGaD
Venlafaxine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00022	0.00708	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000216	0.00694	CbGpPWpGaD
Venlafaxine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000215	0.00691	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—SMO—bone cancer	0.000215	0.0069	CbGpPWpGaD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000205	0.00658	CbGpPWpGaD
Venlafaxine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000201	0.00646	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—RGS1—bone cancer	0.000199	0.00638	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—GRM4—bone cancer	0.000199	0.00638	CbGpPWpGaD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000191	0.00615	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—RGS1—bone cancer	0.00018	0.0058	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—GRM4—bone cancer	0.00018	0.0058	CbGpPWpGaD
Venlafaxine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000176	0.00567	CbGpPWpGaD
Venlafaxine—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000174	0.00559	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—GRM1—bone cancer	0.000172	0.00553	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000172	0.00553	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000165	0.00531	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—GRM1—bone cancer	0.000156	0.00503	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—GSTP1—bone cancer	0.000144	0.00463	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—TGFBR2—bone cancer	0.000144	0.00463	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—GNA11—bone cancer	0.000144	0.00463	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—EZH2—bone cancer	0.000143	0.00461	CbGpPWpGaD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000143	0.00459	CbGpPWpGaD
Venlafaxine—Bronchitis—Doxorubicin—bone cancer	0.000136	0.000745	CcSEcCtD
Venlafaxine—Agranulocytosis—Methotrexate—bone cancer	0.000136	0.000744	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000136	0.00074	CcSEcCtD
Venlafaxine—Pancytopenia—Doxorubicin—bone cancer	0.000135	0.000735	CcSEcCtD
Venlafaxine—Renal failure—Epirubicin—bone cancer	0.000134	0.000733	CcSEcCtD
Venlafaxine—Body temperature increased—Cisplatin—bone cancer	0.000134	0.000732	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Epirubicin—bone cancer	0.000134	0.000731	CcSEcCtD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000133	0.00428	CbGpPWpGaD
Venlafaxine—Stomatitis—Epirubicin—bone cancer	0.000133	0.000727	CcSEcCtD
Venlafaxine—Jaundice—Epirubicin—bone cancer	0.000133	0.000727	CcSEcCtD
Venlafaxine—Conjunctivitis—Epirubicin—bone cancer	0.000133	0.000725	CcSEcCtD
Venlafaxine—Dysuria—Doxorubicin—bone cancer	0.000133	0.000724	CcSEcCtD
Venlafaxine—Neutropenia—Doxorubicin—bone cancer	0.000133	0.000724	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000132	0.00072	CcSEcCtD
Venlafaxine—Haemoglobin—Methotrexate—bone cancer	0.000132	0.000719	CcSEcCtD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000132	0.00423	CbGpPWpGaD
Venlafaxine—Hepatitis—Methotrexate—bone cancer	0.000131	0.000716	CcSEcCtD
Venlafaxine—Haemorrhage—Methotrexate—bone cancer	0.000131	0.000716	CcSEcCtD
Venlafaxine—Sweating—Epirubicin—bone cancer	0.000131	0.000715	CcSEcCtD
Venlafaxine—Pollakiuria—Doxorubicin—bone cancer	0.000131	0.000715	CcSEcCtD
Venlafaxine—Haematuria—Epirubicin—bone cancer	0.00013	0.000711	CcSEcCtD
Venlafaxine—Pharyngitis—Methotrexate—bone cancer	0.00013	0.00071	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000129	0.000707	CcSEcCtD
Venlafaxine—Weight increased—Doxorubicin—bone cancer	0.000129	0.000705	CcSEcCtD
Venlafaxine—Epistaxis—Epirubicin—bone cancer	0.000129	0.000704	CcSEcCtD
Venlafaxine—Weight decreased—Doxorubicin—bone cancer	0.000128	0.0007	CcSEcCtD
Venlafaxine—Sinusitis—Epirubicin—bone cancer	0.000128	0.0007	CcSEcCtD
Venlafaxine—Hyperglycaemia—Doxorubicin—bone cancer	0.000128	0.000698	CcSEcCtD
Venlafaxine—Agranulocytosis—Epirubicin—bone cancer	0.000128	0.000696	CcSEcCtD
Venlafaxine—Pneumonia—Doxorubicin—bone cancer	0.000127	0.000694	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—bone cancer	0.000126	0.00069	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000125	0.000684	CcSEcCtD
Venlafaxine—Hypersensitivity—Cisplatin—bone cancer	0.000125	0.000683	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—bone cancer	0.000125	0.000682	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—bone cancer	0.000124	0.000679	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—GSTP1—bone cancer	0.000124	0.00399	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—TGFBR2—bone cancer	0.000124	0.00399	CbGpPWpGaD
Venlafaxine—Erythema multiforme—Methotrexate—bone cancer	0.000124	0.000677	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000124	0.000677	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—bone cancer	0.000123	0.000673	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—bone cancer	0.000123	0.000673	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—bone cancer	0.000123	0.000673	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—bone cancer	0.000123	0.000671	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—bone cancer	0.000123	0.000671	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—bone cancer	0.000123	0.00067	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—bone cancer	0.000123	0.00067	CcSEcCtD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000123	0.00394	CbGpPWpGaD
Venlafaxine—Tinnitus—Methotrexate—bone cancer	0.000122	0.000667	CcSEcCtD
Venlafaxine—Hypoaesthesia—Epirubicin—bone cancer	0.000122	0.000666	CcSEcCtD
Venlafaxine—Asthenia—Cisplatin—bone cancer	0.000122	0.000665	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—bone cancer	0.000122	0.000665	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—bone cancer	0.000122	0.000664	CcSEcCtD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000122	0.0039	CbGpPWpGaD
Venlafaxine—Sweating—Doxorubicin—bone cancer	0.000121	0.000662	CcSEcCtD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000121	0.00389	CbGpPWpGaD
Venlafaxine—Haematuria—Doxorubicin—bone cancer	0.000121	0.000658	CcSEcCtD
Venlafaxine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00012	0.00385	CbGpPWpGaD
Venlafaxine—Epistaxis—Doxorubicin—bone cancer	0.000119	0.000651	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—bone cancer	0.000119	0.000648	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—bone cancer	0.000118	0.000645	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—bone cancer	0.000118	0.000644	CcSEcCtD
Venlafaxine—Chills—Methotrexate—bone cancer	0.000118	0.000642	CcSEcCtD
Venlafaxine—Diarrhoea—Cisplatin—bone cancer	0.000116	0.000634	CcSEcCtD
Venlafaxine—Erythema multiforme—Epirubicin—bone cancer	0.000116	0.000633	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—bone cancer	0.000116	0.000632	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—bone cancer	0.000116	0.000631	CcSEcCtD
Venlafaxine—Tinnitus—Epirubicin—bone cancer	0.000114	0.000624	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—bone cancer	0.000114	0.000623	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—bone cancer	0.000114	0.000623	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—bone cancer	0.000114	0.000622	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—bone cancer	0.000114	0.000622	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—bone cancer	0.000114	0.000621	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—bone cancer	0.000114	0.00062	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—bone cancer	0.000114	0.00062	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—bone cancer	0.000113	0.000617	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—bone cancer	0.000113	0.000615	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—bone cancer	0.000112	0.00061	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—GNA11—bone cancer	0.000111	0.00357	CbGpPWpGaD
Venlafaxine—Back pain—Methotrexate—bone cancer	0.00011	0.000603	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—SMO—bone cancer	0.00011	0.00354	CbGpPWpGaD
Venlafaxine—Chills—Epirubicin—bone cancer	0.00011	0.000601	CcSEcCtD
Venlafaxine—SLC6A3—NRF2 pathway—TGFBR2—bone cancer	0.00011	0.00353	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—GSTP1—bone cancer	0.00011	0.00353	CbGpPWpGaD
Venlafaxine—Arrhythmia—Epirubicin—bone cancer	0.00011	0.000598	CcSEcCtD
Venlafaxine—Visual impairment—Doxorubicin—bone cancer	0.000109	0.000597	CcSEcCtD
Venlafaxine—Alopecia—Epirubicin—bone cancer	0.000108	0.000592	CcSEcCtD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000108	0.00347	CbGpPWpGaD
Venlafaxine—Vomiting—Cisplatin—bone cancer	0.000108	0.000589	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—bone cancer	0.000108	0.000587	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—bone cancer	0.000107	0.000586	CcSEcCtD
Venlafaxine—Rash—Cisplatin—bone cancer	0.000107	0.000584	CcSEcCtD
Venlafaxine—Dermatitis—Cisplatin—bone cancer	0.000107	0.000584	CcSEcCtD
Venlafaxine—Erythema—Epirubicin—bone cancer	0.000107	0.000583	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—RGS1—bone cancer	0.000107	0.00342	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—GRM4—bone cancer	0.000107	0.00342	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Methotrexate—bone cancer	0.000106	0.000578	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—bone cancer	0.000106	0.000578	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—bone cancer	0.000105	0.000576	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—bone cancer	0.000105	0.000575	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—bone cancer	0.000105	0.000575	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—bone cancer	0.000105	0.000575	CcSEcCtD
Venlafaxine—Tension—Epirubicin—bone cancer	0.000105	0.000572	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—bone cancer	0.000105	0.000571	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—bone cancer	0.000104	0.000566	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—bone cancer	0.000103	0.000564	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—bone cancer	0.000103	0.000562	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—bone cancer	0.000103	0.000561	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—bone cancer	0.000103	0.00056	CcSEcCtD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.000102	0.00329	CbGpPWpGaD
Venlafaxine—Leukopenia—Methotrexate—bone cancer	0.000102	0.000558	CcSEcCtD
Venlafaxine—Chills—Doxorubicin—bone cancer	0.000102	0.000556	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—bone cancer	0.000101	0.000554	CcSEcCtD
Venlafaxine—Nausea—Cisplatin—bone cancer	0.000101	0.00055	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—GNA11—bone cancer	0.000101	0.00324	CbGpPWpGaD
Venlafaxine—Vision blurred—Epirubicin—bone cancer	0.000101	0.000549	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—IL3—bone cancer	0.000101	0.00323	CbGpPWpGaD
Venlafaxine—Alopecia—Doxorubicin—bone cancer	0.0001	0.000548	CcSEcCtD
Venlafaxine—Cough—Methotrexate—bone cancer	9.96e-05	0.000544	CcSEcCtD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.94e-05	0.00319	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Epirubicin—bone cancer	9.91e-05	0.000541	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—bone cancer	9.89e-05	0.00054	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—bone cancer	9.88e-05	0.000539	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—bone cancer	9.87e-05	0.000539	CcSEcCtD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.85e-05	0.00317	CbGpPWpGaD
Venlafaxine—Agitation—Epirubicin—bone cancer	9.82e-05	0.000536	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.75e-05	0.00313	CbGpPWpGaD
Venlafaxine—Flatulence—Doxorubicin—bone cancer	9.74e-05	0.000532	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—bone cancer	9.72e-05	0.00053	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—bone cancer	9.72e-05	0.00053	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—bone cancer	9.72e-05	0.00053	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—bone cancer	9.7e-05	0.000529	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—bone cancer	9.68e-05	0.000528	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—bone cancer	9.63e-05	0.000526	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—bone cancer	9.6e-05	0.000524	CcSEcCtD
Venlafaxine—Nervousness—Doxorubicin—bone cancer	9.6e-05	0.000524	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—bone cancer	9.6e-05	0.000524	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—bone cancer	9.58e-05	0.000523	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—bone cancer	9.56e-05	0.000522	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—bone cancer	9.56e-05	0.000522	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—bone cancer	9.5e-05	0.000519	CcSEcCtD
Venlafaxine—Palpitations—Epirubicin—bone cancer	9.44e-05	0.000515	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—bone cancer	9.39e-05	0.000513	CcSEcCtD
Venlafaxine—Loss of consciousness—Epirubicin—bone cancer	9.39e-05	0.000512	CcSEcCtD
Venlafaxine—Cough—Epirubicin—bone cancer	9.32e-05	0.000509	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—bone cancer	9.32e-05	0.000508	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—bone cancer	9.31e-05	0.000508	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—bone cancer	9.26e-05	0.000505	CcSEcCtD
Venlafaxine—Infection—Methotrexate—bone cancer	9.25e-05	0.000505	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GRM1—bone cancer	9.24e-05	0.00297	CbGpPWpGaD
Venlafaxine—Hypertension—Epirubicin—bone cancer	9.22e-05	0.000503	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—bone cancer	9.17e-05	0.000501	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—IL3—bone cancer	9.14e-05	0.00294	CbGpPWpGaD
Venlafaxine—Anaemia—Doxorubicin—bone cancer	9.14e-05	0.000499	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—bone cancer	9.12e-05	0.000498	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—bone cancer	9.09e-05	0.000496	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—bone cancer	9.09e-05	0.000496	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—bone cancer	9.09e-05	0.000496	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—bone cancer	9.08e-05	0.000496	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—bone cancer	9.06e-05	0.000495	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—bone cancer	9.01e-05	0.000492	CcSEcCtD
Venlafaxine—Discomfort—Epirubicin—bone cancer	8.99e-05	0.00049	CcSEcCtD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.93e-05	0.00287	CbGpPWpGaD
Venlafaxine—Malaise—Doxorubicin—bone cancer	8.91e-05	0.000486	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	8.91e-05	0.00286	CbGpPWpGaD
Venlafaxine—Dry mouth—Epirubicin—bone cancer	8.89e-05	0.000485	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—bone cancer	8.88e-05	0.000485	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—bone cancer	8.88e-05	0.000485	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—bone cancer	8.86e-05	0.000484	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—bone cancer	8.85e-05	0.000483	CcSEcCtD
Venlafaxine—Confusional state—Epirubicin—bone cancer	8.79e-05	0.00048	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—bone cancer	8.73e-05	0.000477	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—bone cancer	8.72e-05	0.000476	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—bone cancer	8.72e-05	0.000476	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—bone cancer	8.7e-05	0.000475	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—bone cancer	8.69e-05	0.000474	CcSEcCtD
Venlafaxine—Infection—Epirubicin—bone cancer	8.66e-05	0.000473	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.64e-05	0.00278	CbGpPWpGaD
Venlafaxine—Cough—Doxorubicin—bone cancer	8.62e-05	0.000471	CcSEcCtD
Venlafaxine—Shock—Epirubicin—bone cancer	8.58e-05	0.000468	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—bone cancer	8.56e-05	0.000467	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—bone cancer	8.54e-05	0.000466	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—bone cancer	8.53e-05	0.000466	CcSEcCtD
Venlafaxine—Tachycardia—Epirubicin—bone cancer	8.51e-05	0.000464	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—bone cancer	8.49e-05	0.000463	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—bone cancer	8.43e-05	0.00046	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—bone cancer	8.43e-05	0.00046	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.42e-05	0.00271	CbGpPWpGaD
Venlafaxine—Chest pain—Doxorubicin—bone cancer	8.41e-05	0.000459	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—bone cancer	8.41e-05	0.000459	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—bone cancer	8.41e-05	0.000459	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—bone cancer	8.39e-05	0.000458	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—bone cancer	8.37e-05	0.000457	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—bone cancer	8.31e-05	0.000454	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—bone cancer	8.31e-05	0.000454	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—bone cancer	8.31e-05	0.000453	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—bone cancer	8.28e-05	0.000452	CcSEcCtD
Venlafaxine—Dry mouth—Doxorubicin—bone cancer	8.23e-05	0.000449	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—bone cancer	8.2e-05	0.000448	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—bone cancer	8.15e-05	0.000445	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—bone cancer	8.13e-05	0.000444	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—bone cancer	8.1e-05	0.000442	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—CDK4—bone cancer	8.1e-05	0.0026	CbGpPWpGaD
Venlafaxine—Anaphylactic shock—Doxorubicin—bone cancer	8.07e-05	0.00044	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—bone cancer	8.07e-05	0.00044	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—bone cancer	8.03e-05	0.000438	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—bone cancer	8.01e-05	0.000437	CcSEcCtD
Venlafaxine—Pain—Methotrexate—bone cancer	7.97e-05	0.000435	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.95e-05	0.00255	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—bone cancer	7.94e-05	0.000434	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—bone cancer	7.94e-05	0.000433	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—bone cancer	7.9e-05	0.000431	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—bone cancer	7.89e-05	0.00043	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—bone cancer	7.87e-05	0.00043	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—bone cancer	7.83e-05	0.000427	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—bone cancer	7.8e-05	0.000426	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—bone cancer	7.77e-05	0.000424	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—bone cancer	7.75e-05	0.000423	CcSEcCtD
Venlafaxine—Anorexia—Doxorubicin—bone cancer	7.69e-05	0.00042	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—bone cancer	7.68e-05	0.000419	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—bone cancer	7.67e-05	0.000419	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—bone cancer	7.62e-05	0.000416	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	7.6e-05	0.00244	CbGpPWpGaD
Venlafaxine—Decreased appetite—Epirubicin—bone cancer	7.58e-05	0.000414	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—bone cancer	7.54e-05	0.000411	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—bone cancer	7.52e-05	0.00041	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	7.49e-05	0.00241	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.46e-05	0.0024	CbGpPWpGaD
Venlafaxine—Constipation—Epirubicin—bone cancer	7.46e-05	0.000407	CcSEcCtD
Venlafaxine—Pain—Epirubicin—bone cancer	7.46e-05	0.000407	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—bone cancer	7.4e-05	0.000404	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—bone cancer	7.36e-05	0.000402	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—bone cancer	7.36e-05	0.000402	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—bone cancer	7.35e-05	0.000401	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.31e-05	0.00235	CbGpPWpGaD
Venlafaxine—Insomnia—Doxorubicin—bone cancer	7.3e-05	0.000398	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—bone cancer	7.24e-05	0.000395	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—bone cancer	7.19e-05	0.000393	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—bone cancer	7.18e-05	0.000392	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—bone cancer	7.17e-05	0.000391	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Epirubicin—bone cancer	7.13e-05	0.000389	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—bone cancer	7.1e-05	0.000388	CcSEcCtD
Venlafaxine—Decreased appetite—Doxorubicin—bone cancer	7.01e-05	0.000383	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—bone cancer	6.95e-05	0.00038	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—bone cancer	6.93e-05	0.000378	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—bone cancer	6.9e-05	0.000376	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—bone cancer	6.9e-05	0.000376	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—bone cancer	6.89e-05	0.000376	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—bone cancer	6.89e-05	0.000376	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—bone cancer	6.86e-05	0.000375	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.86e-05	0.0022	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	6.83e-05	0.0022	CbGpPWpGaD
Venlafaxine—Asthenia—Methotrexate—bone cancer	6.68e-05	0.000365	CcSEcCtD
Venlafaxine—Feeling abnormal—Doxorubicin—bone cancer	6.65e-05	0.000363	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Doxorubicin—bone cancer	6.6e-05	0.00036	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—bone cancer	6.59e-05	0.00036	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—SMO—bone cancer	6.51e-05	0.00209	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—GSTP1—bone cancer	6.5e-05	0.00209	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Epirubicin—bone cancer	6.42e-05	0.000351	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—bone cancer	6.41e-05	0.00035	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	6.41e-05	0.00206	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—JUN—bone cancer	6.39e-05	0.00205	CbGpPWpGaD
Venlafaxine—Abdominal pain—Doxorubicin—bone cancer	6.38e-05	0.000348	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—bone cancer	6.38e-05	0.000348	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—bone cancer	6.37e-05	0.000348	CcSEcCtD
Venlafaxine—Asthenia—Epirubicin—bone cancer	6.25e-05	0.000341	CcSEcCtD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.23e-05	0.002	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	6.21e-05	0.002	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NDUFA12—bone cancer	6.21e-05	0.002	CbGpPWpGaD
Venlafaxine—Pruritus—Epirubicin—bone cancer	6.17e-05	0.000337	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—bone cancer	6.16e-05	0.000336	CcSEcCtD
Venlafaxine—Diarrhoea—Epirubicin—bone cancer	5.96e-05	0.000326	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GNA11—bone cancer	5.95e-05	0.00191	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Doxorubicin—bone cancer	5.94e-05	0.000324	CcSEcCtD
Venlafaxine—Vomiting—Methotrexate—bone cancer	5.92e-05	0.000323	CcSEcCtD
Venlafaxine—Rash—Methotrexate—bone cancer	5.87e-05	0.000321	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—bone cancer	5.87e-05	0.00032	CcSEcCtD
Venlafaxine—Headache—Methotrexate—bone cancer	5.84e-05	0.000319	CcSEcCtD
Venlafaxine—Asthenia—Doxorubicin—bone cancer	5.79e-05	0.000316	CcSEcCtD
Venlafaxine—Dizziness—Epirubicin—bone cancer	5.76e-05	0.000315	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	5.74e-05	0.00184	CbGpPWpGaD
Venlafaxine—Pruritus—Doxorubicin—bone cancer	5.71e-05	0.000311	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	5.66e-05	0.00182	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.66e-05	0.00182	CbGpPWpGaD
Venlafaxine—Vomiting—Epirubicin—bone cancer	5.54e-05	0.000303	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—ATF1—bone cancer	5.54e-05	0.00178	CbGpPWpGaD
Venlafaxine—Nausea—Methotrexate—bone cancer	5.53e-05	0.000302	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—bone cancer	5.52e-05	0.000301	CcSEcCtD
Venlafaxine—Rash—Epirubicin—bone cancer	5.5e-05	0.0003	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—bone cancer	5.49e-05	0.0003	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—BRAF—bone cancer	5.48e-05	0.00176	CbGpPWpGaD
Venlafaxine—Headache—Epirubicin—bone cancer	5.46e-05	0.000298	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—IL3—bone cancer	5.4e-05	0.00173	CbGpPWpGaD
Venlafaxine—Dizziness—Doxorubicin—bone cancer	5.33e-05	0.000291	CcSEcCtD
Venlafaxine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	5.28e-05	0.0017	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.23e-05	0.00168	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—JUN—bone cancer	5.22e-05	0.00168	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	5.21e-05	0.00167	CbGpPWpGaD
Venlafaxine—Nausea—Epirubicin—bone cancer	5.18e-05	0.000283	CcSEcCtD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	5.16e-05	0.00166	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	5.15e-05	0.00166	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NT5C3A—bone cancer	5.15e-05	0.00165	CbGpPWpGaD
Venlafaxine—Vomiting—Doxorubicin—bone cancer	5.13e-05	0.00028	CcSEcCtD
Venlafaxine—Rash—Doxorubicin—bone cancer	5.09e-05	0.000278	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	5.08e-05	0.00163	CbGpPWpGaD
Venlafaxine—Dermatitis—Doxorubicin—bone cancer	5.08e-05	0.000277	CcSEcCtD
Venlafaxine—Headache—Doxorubicin—bone cancer	5.05e-05	0.000276	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.91e-05	0.00158	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.84e-05	0.00156	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.82e-05	0.00155	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—bone cancer	4.79e-05	0.000262	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—TGFBR2—bone cancer	4.62e-05	0.00148	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—MDM2—bone cancer	4.59e-05	0.00148	CbGpPWpGaD
Venlafaxine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.56e-05	0.00146	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NDUFA12—bone cancer	4.55e-05	0.00146	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—GSTP1—bone cancer	4.52e-05	0.00145	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.48e-05	0.00144	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	4.45e-05	0.00143	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.42e-05	0.00142	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IGF1R—bone cancer	4.34e-05	0.0014	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.31e-05	0.00138	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.3e-05	0.00138	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—BRAF—bone cancer	4.2e-05	0.00135	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NT5C3A—bone cancer	3.77e-05	0.00121	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.71e-05	0.00119	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—MDM2—bone cancer	3.52e-05	0.00113	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—bone cancer	3.44e-05	0.00111	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NDUFA12—bone cancer	3.44e-05	0.00111	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NDUFA12—bone cancer	3.36e-05	0.00108	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.19e-05	0.00103	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NDUFA12—bone cancer	3.16e-05	0.00102	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KIT—bone cancer	3.15e-05	0.00101	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NDUFA12—bone cancer	3.14e-05	0.00101	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—BRAF—bone cancer	2.96e-05	0.000951	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.95e-05	0.000948	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.91e-05	0.000935	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—bone cancer	2.87e-05	0.000922	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NT5C3A—bone cancer	2.85e-05	0.000916	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NT5C3A—bone cancer	2.78e-05	0.000894	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NT5C3A—bone cancer	2.62e-05	0.000842	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NT5C3A—bone cancer	2.6e-05	0.000835	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MDM2—bone cancer	2.48e-05	0.000797	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.37e-05	0.000761	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.28e-05	0.000733	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ENO2—bone cancer	2.25e-05	0.000724	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—JUN—bone cancer	2.16e-05	0.000693	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—bone cancer	2.1e-05	0.000674	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—DHFR—bone cancer	2.09e-05	0.000672	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.07e-05	0.000665	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.06e-05	0.000661	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GNA11—bone cancer	1.95e-05	0.000628	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP3A4—bone cancer	1.77e-05	0.000569	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.71e-05	0.000551	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—bone cancer	1.7e-05	0.000545	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ENO2—bone cancer	1.65e-05	0.000531	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.62e-05	0.00052	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—DHFR—bone cancer	1.53e-05	0.000493	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTP1—bone cancer	1.52e-05	0.000487	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GNA11—bone cancer	1.43e-05	0.00046	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—bone cancer	1.42e-05	0.000457	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.36e-05	0.000437	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP3A4—bone cancer	1.3e-05	0.000417	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ENO2—bone cancer	1.25e-05	0.000401	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ENO2—bone cancer	1.22e-05	0.000392	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—DHFR—bone cancer	1.16e-05	0.000372	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ENO2—bone cancer	1.15e-05	0.000369	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ENO2—bone cancer	1.14e-05	0.000366	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—DHFR—bone cancer	1.13e-05	0.000363	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTP1—bone cancer	1.11e-05	0.000357	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GNA11—bone cancer	1.08e-05	0.000348	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—DHFR—bone cancer	1.07e-05	0.000342	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GNA11—bone cancer	1.06e-05	0.00034	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—DHFR—bone cancer	1.06e-05	0.000339	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GNA11—bone cancer	9.96e-06	0.00032	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GNA11—bone cancer	9.87e-06	0.000317	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP3A4—bone cancer	9.82e-06	0.000315	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.77e-06	0.000314	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP3A4—bone cancer	9.58e-06	0.000308	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP3A4—bone cancer	9.03e-06	0.00029	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP3A4—bone cancer	8.95e-06	0.000288	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.91e-06	0.000286	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTP1—bone cancer	8.4e-06	0.00027	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTP1—bone cancer	8.19e-06	0.000263	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—bone cancer	7.85e-06	0.000252	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTP1—bone cancer	7.72e-06	0.000248	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTP1—bone cancer	7.66e-06	0.000246	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ENO2—bone cancer	7.51e-06	0.000241	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—DHFR—bone cancer	6.97e-06	0.000224	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GNA11—bone cancer	6.51e-06	0.000209	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—bone cancer	5.76e-06	0.000185	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTP1—bone cancer	5.05e-06	0.000162	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—bone cancer	4.35e-06	0.00014	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—bone cancer	4.25e-06	0.000136	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—bone cancer	4e-06	0.000129	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—bone cancer	3.97e-06	0.000127	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—bone cancer	2.62e-06	8.4e-05	CbGpPWpGaD
